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We conducted this study to analyze endothelial cell
function within intact thoracic aorta of the systemic
sclerosis murine model, the heterozygous tight-skin
mice 1: (i) assessing the distribution and activation
intensity of endothelial cells, responsive to endothe-
lium-dependent vasodilators (acetylcholine, adenosine
triphosphate, bradykinin, and substance P) and Ilo-
prost, using laser line confocal microscopy in combina-
tion with two Ca2þ £uorescent dyes; (ii) evaluating en-
dothelium-dependent vasodilator- and Iloprostinduced
relaxation, using isometric tension measurement;
and (iii) investigating the role of nitric oxide in mediat-
ing relaxation to acetylcholine and adenosine tripho-
sphate. The number of activated endothelial cells was
signi¢cantly lower in heterozygous tight-skin mice 1,
compared with controls, for adenosine triphosphate
and Iloprost. Maximal increase of Ca2þ £uorescence
intensity ratio in activated endothelial cells was de-
creased for adenosine triphosphate, bradykinin, and Ilo-
prost, in heterozygous tight-skin mice 1. Adenosine
triphosphate- and Iloprost-mediated aortic relaxation
was further impaired in heterozygous tight-skin mice 1.
Finally, aortic relaxation to acetylcholine and adeno-
sine triphosphate was markedly decreased by nitric
oxide synthase inhibitor in heterozygous tight-skin
mice 1. This study suggests that endothelial cell recep-
tors for endothelium-dependent vasodilators and Ilo-
prost may not be homogeneously distributed or
continuously expressed in thoracic aorta of heterozy-
gous tight-skin mice 1, resulting in endothelium-
dependent vasodilatation dysfunction. Moreover, because
endothelium-dependent relaxation was highly depen-
dent on nitric oxide release in heterozygous tight-skin
mice 1, endothelium-dependent relaxation may di¡er
from that of controls by increased production of nitric
oxide. In turn, in heterozygous tight-skin mice 1, the
resulting elevated nitric oxide levels may contribute to
nitric oxide-mediated free radical endothelial cytotoxi-
city, although endothelium impairment may be related
to other factors, particularly: Fbn-1 gene mutation and
transforming growth factor-b. Key words: endothelium-
dependent relaxation/nitric oxide/prostacyclin analog/systemic
sclerosis/tight-skin mice. J Invest Dermatol 119:1379 ^1387,
2002
S
ystemic sclerosis (SSc) is a systemic in£ammatory disor-
der, a¡ecting the skin and other organs (Marie et al, 1998,
2001a, b). The disorder is characterized by three
histopathologic features (LeRoy et al, 1991): (i) both
structural and functional vascular lesions; (ii) perivascu-
lar and tissue in¢ltration of mononuclear in£ammatory cells; and
(iii) increased synthesis and excessive deposition of extracellular
matrix, resulting in ¢brotic destruction of internal organs during
the course of SSc. The pathogenesis of SSc still remains un-
known, although endothelial dysfunction has been suggested as
a key element of the disease process (LeRoy, 1996; Sgonc et al,
1996; Sgonc, 1999).
The understanding of the pathologic mechanisms underlying
SSc requires experimental models that provide valuable tools for
(i) investigating both cellular and molecular pathways involved in
SSc process, and (ii) testing potentially useful therapy (Bocchieri
et al, 1991; Kasturi et al, 1994; Jimenez and Gershwin, 1996; Sgonc
et al, 1996). To date, only few animal models of human SSc are
available (Bocchieri et al, 1991; Kasturi et al, 1994; Jimenez and
Gershwin, 1996; Sgonc et al, 1996). These include the tight-skin 1
(TSK 1) mouse, a spontaneous dominant mutant of the inbred
B10.D2 (58N) Sn mouse strain (Green et al, 1976; Bocchieri
et al, 1991; Kasturi et al, 1994; Jimenez and Gershwin, 1996; Sgonc,
1999). The mutation causing TSK 1 phenotype, which is located
on chromosome 2 (Green et al, 1976; Bocchieri et al, 1991), has been
recently shown to be a 30^40 kb genomic duplication in the
¢brillin-1 (Fbn-1) gene (Siracusa et al, 1996).
The homozygous TSK 1/TSK 1 mice degenerate in utero at 7^8
d of gestation, whereas heterozygous TSK 1mice (TSK 1þ) mice
develop a syndrome mimicking the severe cutaneous and visceral
involvement of SSc (Green et al, 1976; Menton et al, 1978; Menton
and Hess, 1980; Osborn et al, 1987; Bocchieri et al, 1991; Kasturi
et al, 1994; Jimenez and Gershwin, 1996; Siracusa et al, 1996; Sgonc,
1999; Sgonc et al, 1999): (i) marked hyperplasia of loose connective
tissue within the skin, resulting in cutaneous thickening and
induration, and (ii) development of ¢brotic abnormalities in sev-
eral organs. Both skin and organ ¢brosis are related to increased
accumulation of extracellular matrix components (Green et al,
1976; Menton et al, 1978, Menton and Hess, 1980; Osborn et al,
1987; Jimenez and Gershwin, 1996). TSK 1þ mice further show
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positivity for antinuclear antibodies and autoantibodies to: topoi-
somerase I, RNA polymerase I, and Fbn-1 (Menton and Hess,
1980; Muryoi et al, 1992; Shibata et al, 1993; Kasturi et al, 1994,
1995).
Nevertheless, to date,TSK 1þ mice are still considered to lack
severe histologic vascular alterations of human SSc (Green et al,
1976; Bocchieri et al, 1991; Kasturi et al, 1994; Jimenez and Gersh-
win, 1996; Sgonc, 1999; Sgonc et al, 1999). These mice have been
previously shown to develop: (i) cardiac enlargement, which is
not caused by increased blood pressure nor valvular lesions
(Green et al, 1976; Osborn et al, 1987; Jimenez and Gershwin,
1996) (electron microscopic studies have revealed increased
deposits of both thick and dense collagen ¢bers within myocar-
dium, notably in perivascular areas; Osborn et al, 1987); (ii) invol-
vement of aortic wall, characterized by marked hyperplasia of
loose connective tissue, without intimal proliferation on histolo-
gic examination (Kasturi et al, 1994); and (iii) absence of anti-en-
dothelial cell antibody-triggered apoptosis of endothelial cells
(Sgonc et al, 1999). The better way to detect endothelium
abnormalities, however, may require the observation of dynamic
events, occurring in living endothelial cells. The endothelium
has been indeed shown to play an important part in the control
of vascular tone; at least three vasoactive factors, i.e., nitric oxide
(NO), prostacyclin (PGI2) (Moncada and Vane, 1979; Furchgott
and Zawadzki, 1980) and endothelium-derived hyperpolarizing
factor (EDHF) (BeŁ ny and Brunet, 1988), are generated by the
vascular endothelial cells upon exposure to endothelium-depen-
dent vasodilators. The induced release of these endothelium-de-
rived vasodilators, in£uencing the tone of the adjacent smooth
muscles, is considered to be regulated by cytosolic free calcium
([Ca2þ ]i) changes in the endothelial cells (BeŁ ny and Brunet,
1988; Budel et al, 2001; Oishi et al, 2001; Marie and BeŁ ny, 2002);
in turn, endothelium-dependent vasodilators have been
demonstrated to elevate the intracellular levels of [Ca2þ ]i in
endothelial cells.
This prompted us to conduct this study, in order to assess
endothelium reactivity within the intact vascular wall of TSK
1þ mice, in response to endothelium-dependent vasodilators.
The aims of this study were, to analyze functional properties of
living endothelial cells within the intact thoracic aorta wall of
TSK 1þ mice, in vitro, by:
1 Assessing [Ca2þ]i changes in endothelial cells induced by
endothelium-dependent vasodilators [that are, acetylcholine, ade-
nosine 50 -triphosphate (ATP), bradykinin, and substance P] and
a stable analog of PGI2 (Iloprost), using laser line confocal micro-
scopy in combination with two sensitive £uorescent dyes,
i.e., analysis of both the surface of activated endothelial cells and
the £uorescence ratio in activated endothelial cells.
2 Evaluating endothelium-dependent vasodilator-induced
relaxation (i.e., acetylcholine, ATP, bradykinin, and substance
P) and Iloprost-induced relaxation, using isometric tension
measurement.
3 Investigating the potential role of NO in mediating aortic
relaxation in response to endothelium-dependent vasodila-
tors (i.e., acetylcholine and ATP), using isometric tension
measurement.
MATERIALS AND METHODS
Mice TSK 1þ and C57BL/6 pa/pa mice were purchased from the Jackson
Laboratory (Bar Harbor, ME). The C57BL/6 strain was chosen because it
provides the genetic background on which the TSK 1 gene is carried.
Mice were housed in conditions that conformed with the guide
published by the U.S. National Institutes of Health. All animal
procedures were further followed in accordance with institutional
guidelines established by both L’AcadeŁ mie suisse des Sciences meŁ dicales
and La SocieŁ teŁ helveŁ tique des Sciences naturelles: animal experimentation
authorization 31.10.1008/168910.
Twenty adult (3^8 mo old) mice of both sexes were used; as no
di¡erences in the responses of male and female mice were observed, the
data from both sexes have been combined (Bocchieri et al, 1991).
Chemicals Acetylcholine, ATP, U46619 (9,11-dideoxy-9,11-methanoe-
poxyprostaglandin F2), and N
o-nitro-L-arginine methyl ester (L-NAME)
were obtained from Sigma (Buchs, Switzerland). Substance P and
bradykinin were purchased from Bachem Feinchemikalien AG
(Bubendorf, Switzerland). Pluronic acid F-127 was obtained from
Calbiochem (San Diego, CA).
Tissue preparation Mice were anesthetized with urethane. The thoracic
aorta was removed and immediately placed in Krebs^Ringer bu¡er,
aerated with 95% O2 and 5% CO2 gas mixture of the following
composition (mM): NaCl 118.7, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4
1.2, NaHCO3 24.8, D-glucose 10.1, pH 7.4. The artery was cleared from all
adherent fat and connective tissue surrounding the adventitia.
Cytosolic free calcium measurement
Dye loading of endothelial cells The thoracic aorta was opened longitudinally
to form a strip (E 10 mm in length), and washed with Krebs^Ringer buf-
fer to remove the remaining blood clots. Particular attention was paid to
avoid damaging the endothelium.
The endothelial cells were loaded with acetoxymethyl ester form of
both £uorescent calcium indicator dyes: Fura-red and Fluo-4 (Molecular
Probes, Eugene, OR), as previously validated (Budel et al, 2001; Oishi et
al, 2001; Marie and BeŁ ny, 2002). Brie£y, the thoracic aorta was incubated
at 371C for 30 min in a HEPES-bu¡ered saline solution medium (NaCl
145 mM, KCl 5 mM, CaCl2 1 mM, MgSO4 0.5 mM, NaH2PO4 1 mM,
HEPES 20 mM, D-glucose 10.1mM, pH 7.4) containing (i) Fura-red/acetox-
ymethyl ester and Fluo-4/acetoxymethyl ester at concentrations of 20 mM
and 40 mM, respectively, and (ii) pluronic acid F-127 (2% v/v). As reported
previously (Budel et al, 2001; Oishi et al, 2001; Marie and BeŁ ny, 2002), the
use of 2 Ca2þ indicator dyes, in intracellular Ca2þ dynamics study, has the
advantage of minimizing the contribution of artifactual changes in £uor-
escence signals that are not related to [Ca2þ ]i variations in endothelial
cells.
After concomitant loading with both Fura-red/acetoxymethyl ester and
Fluo-4/acetoxymethyl ester, the thoracic aorta was placed in a 1 ml obser-
vation chamber, a coverslip serving as a bottom (as previously described;
Budel et al, 2001; Oishi et al, 2001; Marie and BeŁ ny, 2002). The thoracic
aorta was anchored horizontally to avoid movement; the intimal side faced
down the glass coverslip with a 0.5 mm gap left between both aortic en-
dothelium and glass coverslip, ensuring endothelial homogeneous superfu-
sion (Budel et al, 2001; Oishi et al, 2001; Marie and BeŁ ny, 2002).
Before starting the experimental protocols, the aortic segment was al-
lowed to stabilize for 15 min at 251C within the chamber, which was con-
tinuously infused (at a rate of 1.5 ml per min) with oxygenated (95% O2,
5% CO2) Krebs^Ringer bu¡er; solutions in£ow (i.e., Krebs^Ringer bu¡er
and endothelium-dependent vasodilators) was through a four-port Mani-
fold (World Precision Instruments, Sarasota, FL) with continuous aspira-
tion of e¥uent, which ensured delivery of an endothelium-dependent
vasodilator at accurate concentrations (Budel et al, 2001; Oishi et al, 2001;
Marie and BeŁ ny, 2002). After a 15 min equilibration period, [Ca
2þ]i dy-
namic changes in endothelial cells were investigated in response to the fol-
lowing agents: bradykinin 10^7 M, substance P 10^8 M, acetylcholine 10^5 M,
ATP 3  10^5 M, and Iloprost 10^6 M.
During all experiments, the vasodilator was added for a 1 min period;
this was followed, after a 10 min washing period with oxygenated (95%
O2, 5% CO2) Krebs^Ringer bu¡er, by an additional 1 min period during
which another vasodilator was introduced.
Laser scanning confocal microscopy As described previously (Budel et al, 2001;
Oishi et al, 2001; Marie and BeŁ ny, 2002), dye-loaded aortic endothelial cells
were examined, using an Axiovert 135 M inverted light £uorescence mi-
croscope with a 10 (numerical aperture: 0.3) achromat objective, which
was coupled to a confocal argon ion laser scanning unit (LSM 410, class
3B, Carl Zeiss, Oberkochen, Germany). The 488 nm argon ion laser line
was directed to the sample to excite both £uorescent probes. The emitted
£uorescence was split via a dichroic beam splitter (560 nm), and further
directed concomitantly on to two photomultiplier tubes (PMT) (Budel et
al, 2001; Oishi et al, 2001; Marie and BeŁ ny, 2002): (i) one PMT was
equipped with a long pass ¢lter (590 nm) to record Fura-red emission
(maximal emission: 650 nm), and (ii) the other PMTwas equipped with a
bandpass ¢lter (510^525 nm) to record Fluo-4 emission (maximal emission:
516 nm). The parameters of confocal laser scanning were kept rigorously
constant throughout all experimental procedures (Budel et al, 2001; Oishi
et al, 2001; Marie and BeŁ ny, 2002), notably: (i) pinhole size: 20; (ii) PMT
settings; (iii) image size: 256 256 pixels; and (iv) zoom factor: 4. Both
optical and digital parameters were controlled continuously, during all
tests, using a high-resolution 160 video monitor (IBM compatible control
computer).
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Fluorescent signals emitted by aortic endothelial cells were scanned,
using a time series protocol, to monitor agent-induced cell response, i.e.,
prior to, during, and after the addition of the above-mentioned endothe-
lium-dependent vasodilators. In all series, a total of 40 scans (time scan-
ning: 0.547 s) was carried out at constant 3 s intervals to measure dynamic
variations of [Ca2þ ]i within endothelial cells.
Data analysis Scanned images were transferred on to a MacIntosh G3
equipped with an image analysis software (IP-Laboratory Spectrum Soft-
ware, Scanalytics Inc.,Vienna, MA) for subsequent analysis. As previously
validated (Budel et al, 2001; Oishi et al, 2001; Marie and BeŁ ny, 2002), using
RGB format, the 8-bit signal associated with Fura-red £uorescence was
stored in the red memory (R) and that of Fluo-4 in the green memory
(G). Fluorescence intensities were extracted from each image, using image
analysis software. A program was developed that assigned a £uorescence
ratio to each pixel of an image by dividing the intensity level stored in G
memory with that stored in the R memory (Budel et al, 2001; Oishi et al,
2001; Marie and BeŁ ny, 2002).
Areas for analysis (includingE 220 endothelial cells) were selected, and
£uorescence ratio changes were monitored over the sequence of up to 40
images (Budel et al, 2001; Oishi et al, 2001; Marie and BeŁ ny, 2002); the out-
put enabled £uorescence ratio changes to be plotted over time, as pre-
viously validated (Budel et al, 2001; Oishi et al, 2001; Marie and BeŁ ny,
2002).The processed images were represented as pseudo-colored images ac-
cording to an intensity scale ranging from 0 to 255, lowest and highest in-
tensities being in blue and in red, respectively (Budel et al, 2001; Oishi et al,
2001; Marie and BeŁ ny, 2002).
In all experiments, we investigated the following endothelial cell para-
meters, re£ecting [Ca2þ ]i variations in response to the agents’ infusion, i.e.
(i) the ratio of £uorescence in activated endothelial cells (the agent-induced
maximal £uorescence ratio are expressed as percentages, compared with the
baseline values, and data are presented as mean7SEM of this later percen-
tage, for the number of experiments indicated in parentheses), and (ii) the
spatial surface of area(s) per ¢eld, with £uorescence ratio changes, expressed
as a percentage. Endothelial cells were considered to be activated by vaso-
dilators, when the £uorescence ratio was higher than 5%. Data are pre-
sented as mean7SEM of this later percentage, for the number of
experiments indicated in parentheses.
Isometric tension measurement Two 3^4 mm wide rings were cut
contiguously from the thoracic aorta; care was taken not to damage the
endothelium. The rings were mounted separately for isometric tension
recording, in 5 ml stainless steel organ bath, containing prewarmed
(371C) and oxygenated (95% O2, 5% CO2) Krebs^Ringer bu¡er, with
two ‘‘L-shaped’’ stainless steel hooks slid into both extremities; one
extremity was connected to the lever of a force displacement transducer.
Changes in tension were measured isometrically, using a Mulvany
microvessel Myograph (Multimyograph, model 610 M, Danish Myo
TechnologyA/S, Aarhus, Denmark); all recorded data were digitized with
an analog^digital interface (MacLab,World Precision Instrument) and then
stored on the hard disk of a MacIntosh compatible computer. These
¢ndings were analyzed by a commercially available and validated software
program (MacLab System,World Precision Instrument).
Endothelium-dependent relaxation assessment The study design was as follows.
Passive resting tension of 0.5 mN was initially applied stepwise, and the
rings were allowed to stabilize for 1 h; the applied tension was readjusted
to 0.5 mN at 15 min intervals regularly. Immediately following this 1 h
equilibration period, aortic rings were continuously infused with a de¢nite
concentration (3  10^7 M) of U46619 (thromboxane A2 analog), in order
to achieve maximal contraction. When a stable contraction plateau was
reached, endothelium-dependent relaxation of the aortic rings were tested
in response to: bradykinin (10^7 M), substance P (10^8 M), and Iloprost
10^6 M; two additional agents were added in a noncumulative fashion to
generate a dose^response curve, i.e., (i) acetylcholine, from a 10^9 M to
10^5 M concentration, and (ii) ATP, from a 10^9 M to 10^2 M concentration.
Data are presented as mean7SEM. Relaxation responses are expressed
as percentage of aortic rings’ contraction level force to U46619 (3 10^7 M);
the number of experiments is indicated in parentheses; each aortic ring
served as its own control. Agonist EC50 values were calculated with a sig-
moidal regression analysis, using the computer program GraphPad Prism
(San Diego, CA).
NO endothelium-dependent relaxation assessment The study design was as fol-
lows. A passive resting tension of 0.5 mN was initially applied stepwise,
and the rings were allowed to stabilize for 1 h; the applied tension was
readjusted to 0.5 mN at 15 min intervals regularly. Immediately following
this 1 h equilibration period, aortic rings were continuously infused with a
de¢nite concentration (310^7 M) of U46619, in order to achieve constant
contraction.When a stable contraction plateau was reached, the aortic rings
were incubated with an inhibitor of NO synthase (NOS) (i.e., L-NAME
10^4 M) for 30 min.When a new stable contraction was achieved, endothe-
lium-dependent relaxation of the aortic rings were tested in response to
acetylcholine and ATP, in the presence of L-NAME. These two agents
were added in a noncumulative fashion to generate a dose^response curve,
i.e., (i) acetylcholine concentration: 10^8 M, 10^7 M, 10^6 M, and 10^5 M, and
(ii) ATP concentration: 10^7 M, 10^5 M, 10^3 M, and 10^2 M.
Data are presented as mean7SEM. Relaxation responses are expressed
as a percentage of the aortic rings’ contraction level force to both U46619
(310^7 M) and L-NAME (10^4 M); the number of experiment is indicated
in parentheses; aortic rings’ relaxation, in the absence of L-NAME (10^4 M)
served as controls in both TSK 1þ and control mice.
Statistical analysis Continuous data were expressed as mean7SEM.
Analyses were performed, using StatXact version 3.0 (Cytel Software
Corporation, Cambridge, MA) and StatView version 5.0 (Cytel Software
Corporation, SAS Institute Inc.). Statistical analyses were performed using
the Mann^Whitney test for continuous outcomes. The results were
regarded as signi¢cant when po0.05.
RESULTS
[Ca2þ]i ¢ndings, using laser scanning confocal microscopy,
in endothelial cells of TSK 1þ and control mice
Endothelial cells became £uorescent after the 30 min incubation
period in TSK 1þ and control mice. As illustrated in Fig 1, the
endothelial cells appeared round in shape using PMT1 (Fluo-4)
and PMT2 (Fura-red) settings, respectively.
Acetylcholine As shown in Figs 2 and 3, the surface of activated
endothelial cells, responding to acetylcholine 10^5 M tended to be
lower in TSK 1þ mice compared with controls (69.0674.56% vs
76.9773.67%), although this was not signi¢cant (p¼ 0.227) (Fig
4A); this corresponds to 153 and 170 endothelial cells (of a total
number of 220 endothelial cells within the observed ¢eld) in
TSK 1þ (Fig 2) and control (Fig 3) mice, respectively (n¼15).
The infusion of aortic strips with acetylcholine 10^5 M imme-
diately resulted in a higher increase of activated endothelial cells’
£uorescence ratio (163.16714.38% vs 102.94715.87%; p¼ 0.005)
in TSK 1þ mice compared with controls (n¼15) (Figs 2, 3,
and 4B).
Figure1. Appearance of endothelial cells within intact murine
thoracic aortic wall in vitro, after loading with Fluo-4 and Fura-
red, observed with laser line confocal microscopy.
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ATP The area of activated endothelial cells, in response to ATP
310^5 M infusion, was smaller in TSK 1þ mice compared with
controls (80.1373.26% vs 86.0472.67%; p¼ 0.050) (Figs 2, 3,
and 4A); about 177 and 190 endothelial cells (of a total number
of 220 endothelial cells) showed [Ca2þ ]i increase in TSK 1
þ
(Fig 2) and control (Fig 3) mice, respectively (n¼13).
The infusion of aortic strips with ATP 310^5 M induced a
lower increase of activated endothelial cells’ £uorescence ratio in
TSK 1þ mice compared with controls (135.85713.25% vs
189.02714.85%; p¼ 0.012) (Figs 2, 3, and 4B).
Bradykinin The surface of endothelial cells, activated by bradyki-
nin 10^7 M, tended to be lower in TSK 1þ mice compared with
controls (31.0275.57% vs 41.3476.02%), although not signi¢-
cantly so (p¼ 0.286) (Figs 2, 3, and 4A); about 69 and 91 en-
dothelial cells (of a total number of 220 endothelial cells)
revealed [Ca2þ]i increase in TSK 1
þ (Fig 2) and control (Fig 3)
mice, respectively (n¼ 8).
Bradykinin 10^7 M resulted in a lower increase of activated en-
dothelial cells’ £uorescence ratio in TSK 1þ mice compared with
controls (52.81711.02% vs 90.47715.94%; p¼ 0.041) (n¼ 8)
(Figs 2, 3,and 4B).
Substance P The surface of endothelial cells, activated by sub-
stance P 10^8 M, was similar inTSK 1þ mice compared with con-
trols (42.2675.43% vs 47.6576.07%; p¼ 0.283) (Figs 2,3,and
4A); about 93 and 105 endothelial cells (of a total number of 220
endothelial cells) exhibited [Ca2þ ]i increase in TSK 1
þ and con-
trol mice, respectively (n¼ 8) (Figs 2 and 3).
Substance P 10^8 M tended to induce a lower increase of acti-
vated endothelial cells’ £uorescence ratio, in TSK 1þ mice com-
pared with controls (55.4279.89% vs 71.69711.03%), although
not signi¢cantly so (p¼ 0.248) (n¼ 8) (Figs 2, 3,and 4B).
Iloprost The area of activated endothelial cells, in response to Ilo-
prost infusion, was lower in TSK 1þ mice compared with con-
trols (63.5676.19% vs 82.0973.15%; p¼ 0.025) (Figs 2, 3,and
4A); about 140 and 181 endothelial cells (of a total number of
Figure 2. TSK 1+mice. Distribution and maximal £uorescence ratio of
endothelial cells, within intact aortic wall, responsive to infusion of
endothelium-dependent vasodilators (i.e., acetylcholine 10^5M, ATP
310^5M, bradykinin 10^7M, substance P 10^8M) and Iloprost (10^6M) observed
with laser line confocal microscopy. The ratiometric images were obtained by
dividing Fluo-4/Fura-red emitted £uorescence; they are presented as pseu-
do-colored images according to an intensity scale, lowest and highest va-
lues being in blue and in red, respectively. (i.e., in dark and in light,
respectively, in black and white ¢gures).The left images show the endothe-
lial cells before infusion of endothelium-dependent vasodilators and Ilo-
prost. The graphics demonstrate the kinetics of £uorescence intensity ratio
within activated endothelial cells, in response to endothelium-dependent
vasodilators and Iloprost.
Figure 3. Control mice. Distribution and maximal £uorescence ratio of
endothelial cells, within intact aortic wall, responsive to infusion of en-
dothelium-dependent vasodilators (i.e., acetylcholine 10^5M, ATP 310^5M,
bradykinin 10^7M, substance P 10^8M) and Iloprost (10^6M) observed with
laser line confocal microscopy. The left images show the endothelial cells
before infusion of endothelium-dependent vasodilators and Iloprost. The
graphics demonstrate the kinetics of £uorescence intensity ratio within ac-
tivated endothelial cells, in response to endothelium-dependent vasodila-
tors and Iloprost.
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220 endothelial cells) demonstrated [Ca2þ]i increase in TSK 1
þ
(Fig 2) and control (Fig 3) mice, respectively (n¼10).
The infusion of aortic strips with Iloprost 10^6 M induced a
lower increase of activated endothelial cells’ £uorescence ratio in
TSK 1þ mice compared with controls (46.3976.47% vs
130.09718.53%; p¼ 0.0009) (n¼10) (Figs 2, 3,and 4B).
Isometric tension measurement results
Acetylcholine Endothelium-dependent relaxation to acetylcho-
line was obtained over the concentration range of 10^8 M to 10^5
M in bothTSK 1þ and control mice (n¼ 8) (Fig 5A). Acetylcho-
line 10^7 M caused a similar maximal relaxation of U46619
(310^7 M)-induced contraction (24.5975.33% vs 21.7073.56%;
p¼ 0.698) in TSK 1þ and control mice (Fig 5A). Other concen-
trations of acetylcholine induced similar endothelium-dependent
relaxation of aortic rings in TSK 1þ mice compared with con-
trols, i.e., 10^9 M (p¼ 0.241), 10^8 M (p¼ 0.379), 10^6 M (p¼ 0.464),
and 10^5 M (p¼ 0.883) (Fig 5A).
The EC50 values of acetylcholine (concentration necessary to
cause a half-maximal e¡ect) was 1.5210^8 M and 1.0110^8 M,
in TSK 1þ and control mice, respectively.
ATP As shown in Fig 5B, ATP-related endothelium-
dependent relaxation was observed over the concentration range
of 10^7 M to 10^2 M in both TSK 1þ and control mice (n¼ 8).
ATP 10^2 M caused a higher maximal relaxation of U46619
(310^7 M)-induced contraction (80.6678.37% vs 99.9675.56%;
p¼ 0.045) in TSK 1þ mice compared with controls (Fig 5B).
Other concentrations of ATP resulted in a similar endothelium-
dependent relaxation of aortic rings in TSK 1þ mice compared
with controls, i.e., 10^9 M (p¼ 0.555), 10^7 M (p¼1), 10^5 M
(p¼ 0.256), and 10^3 M (p¼ 0.364) (Fig 5B).
The EC50 values of ATP was 7.9310
^4
M and 1.1910^3 M, in
TSK 1þ and control mice, respectively.
Bradykinin and substance P Bradykinin at a concentration of 10^7 M
induced a similar endothelium-dependent relaxation of aortic
rings in TSK 1þ and control mice (3.2871.17% vs 2.9970.77%;
p¼1) (n¼ 7) (Fig 4).
Substance P 10^8 M also led to similar endothelium-dependent
relaxation of aortic rings in TSK 1þ and control mice
(3.5371.15% vs 4.6270.94%; p¼ 0.666) (n¼ 7) (Fig 4).
Iloprost Iloprost at a concentration of 10^6 M resulted in a lower
endothelium-dependent relaxation of aortic rings in TSK 1þ
mice compared with controls (2.3971.18% vs 7.4570.83%;
p¼ 0.031) (n¼ 8) (Fig 4C).
Contribution of endothelial vasoactive factors, resistant to
NOS inhibitor, in acetylcholine and ATP-related relaxation
Acetylcholine Figure 6 illustrates the contribution of endo-
thelial vasoactive factors, resistant to NOS inhibitor, in the
Figure 4. Reactivity of endothelial cells within thoracic aorta wall
in vitro, in response to endothelium-dependent vasodilators (i.e.,
acetylcholine, ATP, bradykinin, substance P) and Iloprost, was as-
sessed by both laser line confocal microscopy and pharmacologic
tests in TSK 1+and control mice.Values are mean7SEM. The results
were regarded as signi¢cant when po0.05 (p-valueso0.05 and 0.01 are pre-
sented as n and, nnrespectively). (A) Proportions of activated endothelial
cells, in response to infusion of endothelium-dependent vasodilators and
Iloprost, are expressed as percentages of observed ¢elds total surface. (B)
Maximal £uorescence ratio of activated endothelial cells, in response to in-
fusion of endothelium-dependent vasodilators and Iloprost, are expressed
as percentages of the baseline values. (C) Endothelium-dependent vasodi-
lator- and Iloprost-induced relaxation of thoracic aortic rings with intact
endothelium, using isometric tension measurement. The relaxation values
are expressed as percentages of contraction to U46619 (310^7 M)
Figure 5. Concentration^relaxation curves to both acetylcholine (A)
and ATP (B) in thoracic aortic rings with intact endothelium of
TSK 1+(@J@) and control (@’@) mice.
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endothelium-dependent acetylcholine-related relaxation in TSK
1þ and control mice (n¼ 8).
In the presence of L-NAME, endothelium-dependent relaxa-
tion to acetylcholine concentrations ranging from 10^8 M to 10^5
M were markedly inhibited in TSK 1þ mice, i.e., 10^8 M
(p¼ 0.005), 10^7 M (p¼ 0.007), 10^6 M (p¼ 0.001), and 10^5 M
(p¼ 0.001) (Fig 6A). In contrast, inhibition of endothelium-
dependent relaxation to acetylcholine was lower in control mice,
i.e., 10^8 M (p¼ 0.465), 10^7 M (p¼ 0.631), 10^6 M (p¼ 0.029), and
10^5 M (p¼ 0.045) (Fig 6B).
ATP Figure 7 demonstrates the contribution of endothelial
vasodilators, resistant to NOS inhibitor, in the endothelium-
dependent relaxation to ATP in TSK 1þ and control mice
(n¼ 8).
In the presence of L-NAME, endothelium-dependent relaxa-
tion to ATP concentrations ranging from 10^7M to 10^2M were
highly inhibited in TSK 1þ mice, i.e., 10^7M (p¼ 0.050), 10^5M
(p¼ 0.001), 10^3M (p¼ 0.001), and 10^2M (p¼ 0.08) (Fig 7A).
Decrease of endothelium-dependent relaxation to acetylcholine
was lower in control mice, i.e., 10^7M (p¼ 0.033), 10^5M
(p¼ 0.011), 10^3M (p¼ 0.004), and 10^2M (p¼ 0.263) (Fig 7B).
DISCUSSION
SSc is characterized by a complex ¢brotic lesion of connective
tissue, and changes in the vascular bed, including concentric inti-
mal proliferation, ¢brous thickening of the media, and abnormal
telangiectasia of the vasa vasorum within the adventitia (D’Ange-
lo et al, 1969; Norton and Nardo, 1970). Microcirculatory dysfunc-
tion is well described in SSc patients, manifesting as (i) Raynaud’s
phenomenon, digital infarcts, and gangrene (Belch, 1991; Youssef
et al, 1993; Veale et al, 1995; Herrick, 2000; Ho et al, 2000), and (ii)
impairment of various organs, e.g., the heart, the kidney, and the
lungs (Veale et al, 1995; Sta¡ord et al, 1998; Nishijima et al, 2001).
Whether vascular involvement has been considered to be
mainly microvascular in SSc, macrovascular disease has been lar-
gely unrecognized until recent years in these patients (D’Angelo et
al, 1969;Youssef et al, 1993;Veale et al, 1995; Sta¡ord et al, 1998; Her-
rick, 2000); however, to date, many comparative studies have
highlighted the high prevalence of large vessel disorders in SSc
(Youssef et al, 1993; Veale et al, 1995; Sta¡ord et al, 1998; Ho et al,
2000). Youssef et al (1993) showed that SSc patients exhibited a
3-fold increase of symptomatic vascular disease, compared with
controls. Veale et al (1995) also mentioned a greater frequency of
symptomatic peripheral arterial obstructive disease, as de¢ned by
theWHO questionnaire for intermittent claudication in SSc pa-
tients than in controls (21.7% vs 4.6%). Moreover, Ho et al (2000)
noted that macrovascular disease, assessed using noninvasive vas-
cular tests (i.e., carotid duplex scanning, measurement of ankle
brachial blood pressure index) was more common in SSc patients
than in control subjects, and particularly (i) carotid artery disease
(64% vs 35%), and (ii) peripheral arterial disease (17% vs 0%).
Recently, SSc patients have been also shown to exhibit dimin-
ished endothelium-dependent vasodilatation, in response to acet-
ylcholine or substance P infusion, in acral, skin, pulmonary, and
renal circulation (Cailes et al, 1998; Freedman et al, 1999, 2001).
These ¢ndings of high frequency of both macrovascular im-
pairment and impaired endothelium-dependent vasodilatation in
SSc patients prompted us to conduct this study, in order to assess
endothelium reactivity within intact macrovascular wall (i.e.,
thoracic aorta) of murine model of SSc that are TSK 1þ mice,
in response to endothelium-dependent vasodilators.
Until now,TSK 1þ mice had been previously shown to devel-
op macrovascular damage, i.e., (i) cardiac enlargement, with his-
tologic electron microscopic analysis revealing increased deposits
of both thick and dense collagen ¢bers within myocardium, no-
tably in perivascular areas (Green et al, 1976; Osborn et al, 1987;
Jimenez and Gershwin, 1996), and (ii) involvement of aortic wall,
Figure 6. Concentration^relaxation curves to acetylcholine without
and with incubation with NO (L-NAME, 10^4M) inhibitor. (A) Con-
centration^relaxation curves to acetylcholine in TSK 1+ mice, without
(VJV) and with (VV) incubation with NO inhibitor. (B) Concentra-
tion^relaxation curves to acetylcholine in control mice, without (V&V)
and with (V’V) incubation with NO inhibitor.
Figure 7. Concentration^relaxation curves to ATP without and with
incubation with NO (L-NAME, 10^4M) inhibitor. (A) Concentration^
relaxation curves to ATP in TSK 1+ mice, without (VJV) and with
(VV) incubation with NO inhibitor. (B) Concentration^relaxation
curves to ATP in control mice, without (V&V) and with (V’V) incu-
bation with NO inhibitor.
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characterized by marked hyperplasia of loose connective tissue on
histologic examination (Kasturi et al, 1994).
The understanding of biologic phenomena pathogenesis, how-
ever, does not only require the knowledge about both histologic
damage and intracellular concentration of biologically active
compounds; in turn, the better way to detect endothelium
abnormalities may require the observation of dynamic events,
occurring in living endothelial cells. Laser scanning confocal mi-
croscopy imaging studies have therefore proved helpful in the
study of cell structure and function. Moreover, many investiga-
tors have validated that laser scanning confocal microscopy, in
combination with Ca2þ £uorescent indicators, particularly
Fluo-4 and Fura-red (Budel et al, 2001; Oishi et al, 2001; Marie
and BeŁ ny, 2002), accurately allows the visualization of Ca
2þ £uc-
tuations in endothelial cells (Budel et al, 2001; Oishi et al, 2001;
Marie and BeŁ ny, 2002). These data are particularly relevant, as
[Ca2þ]i changes in endothelial cells have been demonstrated to
regulate the tone of the adjacent smooth muscles (Budel et al,
2001; Oishi et al, 2001; Marie and BeŁ ny, 2002).We have therefore
investigated [Ca2þ ]i changes in aortic endothelial cells of TSK 1
þ
mice.
Distribution of activated aortic endothelial cells, responsive
to both endothelium-dependent vasodilators and Iloprost in
TSK 1þ and control mice This study is, to the best of our
knowledge, one of the ¢rst to evaluate the accurate distribution
of responsive endothelial cells to endothelium-dependent
vasodilators and to Iloprost, in the murine model of SS:TSK 1þ
mice.
Within intact thoracic aorta, in vitro, we have observed that the
number of endothelial cells, responding to endothelium-
dependent vasodilators, was signi¢cantly lower in TSK 1þ mice
for ATP and Iloprost.
Another main ¢nding, in our series, was that the maximal
Ca2þ £uorescence intensity ratio of endothelial cells was
markedly lower in TSK 1þ mice compared with controls, for
the following agents: endothelium-dependent vasodilators (i.e.,
ATP and bradykinin) and Iloprost (p¼ 0.0009); mean maximal
increase of Ca2þ £uorescence intensity ratio, in endothelial cells
of TSK 1þ mice, was one-third to a half of that observed in
control mice.
From a practical point of view, our observations suggest that
endothelial cell receptors for endothelium-dependent
vasodilators and Iloprost, involving the thoracic aortic wall, may
not have similar expression levels or homogeneous distribution
in TSK 1þ mice compared with controls. These observed
functional abnormalities of endothelial cell data may be
associated with impaired vasodilatation of blood vessels in TSK
1þ mice, as this has been demonstrated in healthy mice (Marie
and BeŁ ny, 2002).
Endothelium-dependent vasodilator-induced relaxation and
Iloprost-induced relaxation in TSK 1þ mice This study
further shows macrovascular dysfunction in TSK 1þ mice, as
determined by the impairment of both ATP- and Iloprost-
mediated control of aortic tone.
Our data do not permit us to explain the reasons of such
impaired control of aortic tone in TSK 1þ mice, in response to
ATP and Iloprost. Aortic wall tone dysfunction, however, in
response to these endothelium-dependent agents, may be
jeopardized in TSK 1þ mice by (i) endothelial injury and
modi¢ed expression of endothelial cell receptors, and (ii)
impairment of vasoactive factors production (NO, PGI2, or
EDHF), which are generated by endothelial cells upon exposure
to endothelium-dependent vasodilators.
Role of NO in endothelium-dependent relaxation in TSK
1þ mice NO plays an important part in regulating the
endothelium-dependent relaxation of adjacent smooth muscle
(Moncada and Vane, 1979; Furchgott and Zawadzki, 1980), and it
is generated endogenously from L-arginine by oxidation to
L-citrulline and NO; this reaction is catalyzed by a group of
related NO enzymes, including inducible NOS and endothelial
NOS (Yamamoto et al, 1998).
The last main ¢nding, in our study, is therefore that the
vascular relaxation pathways of endothelium-dependent
vasodilators (acetylcholine and ATP) di¡er in TSK 1þ mice
compared with controls. In this instance, incubation of thoracic
aorta with L-NAME resulted in higher inhibition of the
endothelium-dependent relaxation in TSK 1þ mice compared
with controls; in turn, our ¢ndings highlight that the relaxation
e¡ects of both acetylcholine and ATP are mainly dependent on
the release of NO in TSK 1þ mice, whereas they are dependent
of other vasoactive factors commonly recognized as EDHF and
PGI2 in control mice.
Our data further suggest that the endothelium-dependent
mediated relaxation of thoracic aorta in TSK 1þ mice may di¡er
from that of controls by increased production of NO, either
initially or due to EDHF and/or PGI2 underproduction. In
TSK 1þ mice, elevated production of NO may have, in part,
contributed to (i) NO-mediated free radical damage of
endothelial cells (Yamamoto et al, 1998), and (ii) worsening the
underlying abnormal regulation of ¢broblasts, increasing ¢brosis
(Yamamoto et al, 1998).
Recent studies have also underlined that NO may be produced
in excess within the skin of SSc patients, contributing to tissue
injury (Yamamoto et al, 1998; Cotton et al, 1999).
Our data do not permit us, in fact, to explain de¢nitely the
mechanisms of endothelium reactivity disturbances, in response
to endothelium-dependent vasodilators, in TSK 1þ mice, i.e.,
impaired control of aortic tone, abnormal distribution of
activated endothelial cells, and increased role of NO in
endothelium-dependent relaxation. According to previous
studies, however, endothelial cell dysfunction within the
thoracic aortic wall of TSK 1þ mice may be due to the e¡ects
of many factors, and particularly to (i) Fbn-1 gene mutation,
and (ii) transforming growth factor (TGF)-b, which has also
been noted to play a part in the pathogenesis of SSc (Furst and
Clements, 1996; Matucci-Cerinic et al, 1996).
The mutation causing the TSK 1 phenotype has been recently
shown to be a 30^40 kb genomic tandem duplication in the
Fbn-1 gene on chromosome 2 (Siracusa et al, 1996; Kielty et al,
1998; Dietz and Mecham, 2000; Saito et al, 2000), and few
investigators have postulated that Fbn-1 gene mutation may be
responsible for the SSc-like phenotype of TSK 1þ mice
(Siracusa et al, 1996; Kielty et al, 1998; Dietz and Mecham, 2000;
Saito et al, 2000; McGaha et al, 2001). These data are particularly
relevant, as (i) numerous microsatellites alleles near the Fbn-1
gene have been similarly described in SSc patients, who exhibit
both microvascular and macrovascular impairment (Tan et al,
1998), and (ii) Fbn-1 gene mutation has also been identi¢ed in
patients with Marfan syndrome, resulting in abnormally loose
connective tissue with skin hyperextensibility and cardiovascular
system impairment, i.e., aortic root dilatation, mitral valve
prolapse, aortic regurgitation, and aneurysms (Siracusa et al, 1996;
Kielty et al, 1998).
In TSK 1þ mice, the Fbn-1 gene mutation results in both
altered structure and function of the encoded mutated Fbn-1
protein, which is a key component of extracellular matrix
micro¢brils involved in elastin assembly (Siracusa et al, 1996;
Kielty et al, 1998; Gayraud et al, 2000). Indeed, the mutated TSK
1þ/Fbn-1 protein has been shown to polymerize and become
incorporated into beaded micro¢brils, leading to structure
impairment of the extracellular matrix (Siracusa et al, 1996;
Kielty et al, 1998; Saito et al, 1999, 2000; Gayraud et al, 2000;
Oble and Teh, 2001). Therefore, we suggest that the Fbn-1 gene
mutation, which is responsible for structural abnormalities of
connective tissue within internal organs, and notably in the
cardiovascular system (i.e., heart, aorta), may have, in part,
contributed to functional abnormalities of endothelial cells and
particularly to the dysfunction of endothelium-dependent
vascular tone in TSK 1þ mice of this study.
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Secondly, the mutated TSK 1þ/Fbn-1 protein has been also
noted to be less stable, and after processing generates
immunogenic epitopes able to stimulate T cells (Saito et al, 2000)
(i) cooperating with B cells, producing anti-Fbn-1
autoantibodies, which are found in TSK 1þ mice, and (ii)
producing ¢brogenic cytokines (and particularlyTGF-b), with a
negative impact on endothelial cells. These latter humoral- and
cellular-induced disturbances may have also led to impairment
of endothelium reactivity in response to endothelium-
dependent vasodilators in our TSK 1þ mice.
Thirdly, there is evidence that TGF-b has an elevated a⁄nity
for the mutated Fbn-1 gene product in vitro in TSK 1þ mice
(Saito et al, 1999; Dietz and Mecham, 2000). Interestingly,TGF-b
is considered to be the primary ¢brogenic growth factor in SSc
by stimulating ¢broblast both proliferation and collagen synthesis
(Pablos et al, 1995; Furst and Clements, 1996, 1997; Varga and
Jimenez, 1996; Saito et al, 2000; McGaha et al, 2001). Indeed,
mutant Fbn-1 of TSK 1þ mice has an increased number of
TGF-b repeats, which allows binding of more TGF-b, leading
to enhanced activity of TGF-b (Siracusa et al, 1996; Saito et al,
2000; McGaha et al, 2001). Finally, whether enhanced activity of
TGF-b plays a part in the development of ¢brosis in TSK 1þ
mice, we further suggest that it may have also favor the
observed vascular impairment in our TSK 1þ mice, because
TGF-b has been shown to inhibit in vitro the proliferation of
endothelial cells, being both cytostatic and cytotoxic for these
cells (Matucci-Cerinic et al, 1996); in turn, TGF-b leads to (i)
direct inhibition of the angiogenic stimulatory e¡ect of
¢broblast growth factor, and (ii) induction of ¢bronectin release,
which reduces endothelial proliferation (Matucci-Cerinic et al,
1996).
In conclusion, this study is, to the best of our knowledge, one
of the ¢rst to demonstrate impairment of endothelium reactivity
within the intact vascular wall of thoracic aorta in TSK 1þ mice,
in response to endothelium-dependent vasodilators. This study
suggests that endothelial cell receptors for endothelium-
dependent vasodilators may not be homogeneously distributed
or continuously expressed within the thoracic aorta of TSK 1þ
mice, resulting in abnormal vasodilatation in TSK 1þ mice.
Moreover, we have demonstrated that endothelium-dependent
relaxation to ATP and acetylcholine was highly dependent on
the release of NO in TSK 1þ mice. Our ¢ndings suggest that
endothelium-dependent mediated relaxation of thoracic aorta in
TSK 1þ mice may di¡er from that of controls by: increased
production of NO, either initially or due to EDHF and/or PGI2
underproduction. In turn, in TSK 1þ mice, increased levels of
NO may contribute to NO-mediated free radical cytotoxicity
for endothelial cells. Finally, our data do not permit us to
explain de¢nitely the mechanisms of endothelium reactivity
abnormalities within intact vascular wall in TSK 1þ mice.
According to previous authors’ data, however, endothelial cell
dysfunction within the thoracic aortic wall may be due to the
e¡ects of two factors in TSK 1þ mice, i.e., (i) Fbn-1 gene
mutation, and (ii) TGF-b.
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